SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?


To: james who wrote (2878)11/19/1997 6:37:00 AM
From: Andreas Helke  Respond to of 6136
 
Take a look into the 10K file. Agouron has 23 compounds in various stages of preclinical and clinical development. They got a few extra compounds with the Alanex aquisition. I remember several cancer treatments, protease inhibitors for a few more viruses, a diabetes treatment.

Andreas